封面
市場調查報告書
商品編碼
1810925

2025年全球心房間分流裝置市場報告

Interatrial Shunt Devices Global Market Report 2025

出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年心房分流裝置市場將快速成長,到2029年將達到42.8億美元,年複合成長率(CAGR)為10.2%。預測期內的成長與以下因素相關:心臟衰竭盛行率上升、老年人口成長、人們對微創心臟手術的認知不斷提高、醫療保健支出不斷成長以及導管療法的普及。這段時期的主要趨勢包括分流裝置材料的創新、技術主導的介入器材微型化、即時成像和導航技術的整合、導管輸送方法的進步以及血流動力學監測系統的改進。

心臟衰竭盛行率的不斷上升預計將在未來幾年推動心臟房間分流裝置市場的成長。心臟衰竭是指心臟無法有效泵血,導致身體組織供氧和營養不足的一種疾病。心臟衰竭患者的增加很大程度上是由於高血壓的日益流行,高血壓逐漸削弱了心臟的泵血功能。心臟房間分流裝置透過在左心房和右心房之間開一個小口,將超負荷的左心房的多餘壓力轉移到右心房來緩解,從而幫助控制心臟衰竭。這可以減少肺部充血並緩解症狀。例如,美國專業組織美國心臟衰竭協會在 2024 年 9 月報告稱,約有 670 萬 20 歲及以上的美國患有心臟衰竭。預計到 2050 年,這一數字將增至 1,140 萬。因此,心臟衰竭盛行率的不斷上升正在推動心臟房間分流裝置市場的擴張。

心臟房間分流裝置市場的關鍵參與者正專注於創新發展,例如首次人體 (FIH) 臨床試驗,以評估旨在降低心臟衰竭患者左心房壓力的新型分流技術的安全性和有效性。首次人體臨床試驗是在成功的臨床前研究之後在人體中測試新醫療設備或藥物的早期階段,以評估安全性、耐受性和初步療效。例如,2025 年 1 月,美國醫療技術公司 Adona Medical Inc. 完成了其首次人體 (FIH) 臨床試驗 ATHENS-HF 的招募,該試驗旨在治療心臟衰竭的新型心臟房間分流術。該設備是首批將治療性分流術與綜合雙心房壓力監測相結合的設備之一,為心臟衰竭管理提供了更具適應性和個性化的方法。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場:宏觀經濟情景,包括利率、通膨、地緣政治、貿易戰和關稅,以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球心臟房間分流裝置:PESTEL分析(政治、社會、科技、環境、法律因素、促進因素與限制因素)
  • 最終用途產業分析
  • 全球心臟房間分流裝置市場:成長率分析
  • 全球心臟房間分流裝置市場表現:規模與成長,2019-2024
  • 全球心臟房間分流裝置市場預測:規模與成長,2024-2029年,2034年
  • 全球心臟房間分流裝置:總目標市場(TAM)

第6章 市場細分

  • 全球心臟房間分流裝置市場:按設備類型、性能和預測,2019-2024 年、2024-2029 年、2034 年
  • 植入式分流裝置
  • 臨時分流裝置
  • 全球心臟房間分流裝置市場(按交付方式、性能和預測),2019-2024 年、2024-2029 年、2034 年
  • 手術分娩
  • 經導管輸送
  • 全球心臟房間分流裝置市場:依材料、性能及預測,2019-2024 年、2024-2029 年、2034 年
  • 鎳鈦合金
  • 聚酯纖維
  • 聚丙烯
  • 全球心臟房間分流裝置市場:應用、效能及預測(2019-2024 年、2024-2029 年及 2034 年)
  • 先天性心臟疾病
  • 心臟衰竭
  • 預防中風
  • 全球心臟房間分流裝置市場:依最終用戶、績效及預測,2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 門診手術中心
  • 心導管實驗室
  • 其他用戶
  • 全球心臟房間分流裝置市場:依植入式分流裝置細分(按類型)、實際及預測,2019-2024 年、2024-2029 年、2034 年
  • 單腔分流裝置
  • 可擴展分流裝置
  • 多腔分流裝置
  • 全球心臟房間分流裝置市場:按臨時分流裝置細分(按類型)、實際及預測,2019-2024 年、2024-2029 年、2034 年
  • 球囊輔助分流裝置
  • 經皮臨時分流裝置
  • 導管分流裝置

第7章 區域和國家分析

  • 全球心臟房間分流裝置市場:依地區、績效及預測,2019-2024 年、2024-2029 年、2034 年
  • 全球心臟房間分流裝置市場:依國家/地區、績效及預測,2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章:中國市場

第10章 印度市場

第11章 日本市場

第12章:澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章:德國市場

第18章:法國市場

第19章:義大利市場

第20章:西班牙市場

第21章 東歐市場

第22章:俄羅斯市場

第23章 北美市場

第24章美國市場

第25章:加拿大市場

第26章 南美洲市場

第27章:巴西市場

第28章 中東市場

第29章:非洲市場

第30章:競爭格局與公司概況

  • 心臟房間分流裝置市場:競爭格局
  • 心臟房間分流裝置市場:公司簡介
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc. Overview, Products and Services, Strategy and Financial Analysis
    • Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章:其他領先和創新企業

  • Cook Medical
  • Integra LifeSciences Holdings Corporation
  • Lepu Medical Technology(Beijing)Co. Ltd.
  • B. Braun Melsungen AG.
  • WL Gore & Associates Inc.
  • Venus Medtech Inc.
  • Occlutech Holding AG.
  • Wuhan Vickor Medical Technology Co. Ltd.
  • Corvia Medical Inc.
  • Xeltis BV
  • Alleviant Medical Inc.
  • Cerevasc Inc.
  • Adona Medical Inc.
  • Carag AG.
  • InterShunt Technologies Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章:高潛力市場國家、細分市場與策略

  • 2029年心臟房間分流裝置市場:提供新機會的國家
  • 2029年心臟房間分流裝置市場:細分市場帶來新機會
  • 2029年心臟房間分流裝置市場:成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r37027

Interatrial shunt devices are implantable medical tools developed to create a controlled passage between the left and right atria of the heart, aiming to lower pressure and alleviate symptoms in heart failure patients. These devices help redirect blood flow from the left atrium to the right atrium, effectively reducing elevated left atrial pressure associated with heart failure.

The primary types of interatrial shunt devices include implantable shunt devices and temporary shunt devices. Implantable shunt devices are designed to create a regulated connection between different body compartments and are typically used to redirect fluid or pressure for therapeutic purposes. These devices can be placed via surgical procedures or transcatheter methods. Common construction materials include nitinol, polyester, and polypropylene. They are primarily used in the treatment of congenital heart defects, heart failure, and stroke prevention, and are employed across various healthcare settings such as hospitals, ambulatory surgical centers, cardiac catheterization labs, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The interatrial shunt devices market research report is one of a series of new reports from The Business Research Company that provides interatrial shunt devices market statistics, including the interatrial shunt devices industry's global market size, regional shares, competitors with the interatrial shunt devices market share, detailed interatrial shunt devices market segments, market trends and opportunities, and any further data you may need to thrive in the interatrial shunt devices market. This interatrial shunt devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The interatrial shunt devices market size has grown rapidly in recent years. It will grow from $2.63 billion in 2024 to $2.90 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth during the historic period can be attributed to increasing clinical evidence validating efficacy and safety, heightened demand for effective pulmonary hypertension management, a rising incidence of related comorbidities, more regulatory approvals for investigational shunt systems, and a growing preference for outpatient and ambulatory cardiac care.

The interatrial shunt devices market size is expected to see rapid growth in the next few years. It will grow to $4.28 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The expected growth in the forecast period can be linked to the increasing prevalence of heart failure, an expanding elderly population, heightened awareness of minimally invasive cardiac procedures, rising healthcare spending, and greater adoption of catheter-based treatments. Key trends during this period include innovations in shunt device materials, technology-driven miniaturization of interventional devices, integration of real-time imaging and navigation technologies, advancements in catheter-based delivery methods, and improvements in hemodynamic monitoring systems.

The increasing prevalence of heart failure is expected to drive the growth of the interatrial shunt devices market in the coming years. Heart failure is a condition where the heart cannot pump blood effectively, leading to insufficient delivery of oxygen and nutrients to the body's tissues. The rise in heart failure cases is largely due to the growing incidence of hypertension, which gradually weakens the heart's pumping ability. Interatrial shunt devices assist in managing heart failure by creating a small opening between the left and right atria, allowing excess pressure from the overloaded left atrium to be relieved by transferring it to the right atrium. This helps reduce pulmonary congestion and alleviates symptoms. For example, in September 2024, the Heart Failure Society of America, a US-based professional organization, reported that approximately 6.7 million Americans aged 20 and older were living with heart failure in 2024. This figure is expected to rise to 11.4 million by 2050. Consequently, the growing prevalence of heart failure is propelling the expansion of the interatrial shunt devices market.

Key players in the interatrial shunt devices market are concentrating on innovative developments, such as first-in-human (FIH) clinical trials to assess the safety and effectiveness of new shunt technologies aimed at lowering left atrial pressure in heart failure patients. A first-in-human clinical trial is the initial phase of testing a new medical device or drug in humans to evaluate safety, tolerability, and early efficacy following successful preclinical research. For instance, in January 2025, Adona Medical Inc., a US-based medical technology company, completed enrollment for its first-in-human (FIH) clinical trial, ATHENS-HF, involving a novel interatrial shunt designed for heart failure treatment. This device is among the first to combine therapeutic shunting with integrated bi-atrial pressure monitoring, offering a more adaptive and personalized method of managing heart failure.

In October 2024, Johnson & Johnson, a US-based pharmaceutical company, acquired V-Wave Ltd. for an undisclosed sum. This acquisition aims to strengthen Johnson & Johnson's cardiovascular portfolio by adding advanced heart failure therapies and addressing critical unmet needs in the sector. V-Wave Ltd. is an Israel-based medical device firm specializing in innovative interatrial shunt devices.

Major players in the interatrial shunt devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc., Terumo Corporation, Edwards Lifesciences Corporation, Cook Medical, Integra LifeSciences Holdings Corporation, Lepu Medical Technology (Beijing) Co. Ltd., B. Braun Melsungen AG., W. L. Gore & Associates Inc., Venus Medtech Inc., Occlutech Holding AG., Wuhan Vickor Medical Technology Co. Ltd., Corvia Medical Inc., Xeltis BV, Alleviant Medical Inc., Cerevasc Inc., Adona Medical Inc., Carag AG., InterShunt Technologies Inc.

North America was the largest region in the interatrial shunt devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in interatrial shunt devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the interatrial shunt devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The interatrial shunt devices market consists of sales of catheter-based delivery tools, transseptal access kits, monitoring accessories, and procedure-specific consumables. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Interatrial Shunt Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on interatrial shunt devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for interatrial shunt devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The interatrial shunt devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Device Type: Implantable Shunt Devices; Temporary Shunt Devices
  • 2) By Delivery Method: Surgical Delivery; Transcatheter Delivery
  • 3) By Material: Nitinol; Polyester; Polyproplene
  • 4) By Application: Congenital Heart Disease; Heart Failure; Stroke Prevention
  • 5) By End-User: Hospitals; Ambulatory Surgical Centers; Cardiac Catheterization Laboratories; Other Users
  • Subsegments:
  • 1) By Implantable Shunt Devices: Single-Lumen Shunt Devices; Expandable Shunt Devices; Multi-Lumen Shunt Devices
  • 2) By Temporary Shunt Devices: Balloon-Assisted Shunt Devices; Percutaneous Temporary Shunt Devices; Catheter-Based Shunt Devices
  • Companies Mentioned: Johnson & Johnson; Abbott Laboratories; Medtronic plc.; Terumo Corporation; Edwards Lifesciences Corporation; Cook Medical; Integra LifeSciences Holdings Corporation; Lepu Medical Technology (Beijing) Co. Ltd.; B. Braun Melsungen AG.; W. L. Gore & Associates Inc.; Venus Medtech Inc.; Occlutech Holding AG.; Wuhan Vickor Medical Technology Co. Ltd.; Corvia Medical Inc.; Xeltis BV; Alleviant Medical Inc.; Cerevasc Inc.; Adona Medical Inc.; Carag AG.; InterShunt Technologies Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Interatrial Shunt Devices Market Characteristics

3. Interatrial Shunt Devices Market Trends And Strategies

4. Interatrial Shunt Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Interatrial Shunt Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Interatrial Shunt Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Interatrial Shunt Devices Market Growth Rate Analysis
  • 5.4. Global Interatrial Shunt Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Interatrial Shunt Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Interatrial Shunt Devices Total Addressable Market (TAM)

6. Interatrial Shunt Devices Market Segmentation

  • 6.1. Global Interatrial Shunt Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implantable Shunt Devices
  • Temporary Shunt Devices
  • 6.2. Global Interatrial Shunt Devices Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Surgical Delivery
  • Transcatheter Delivery
  • 6.3. Global Interatrial Shunt Devices Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nitinol
  • Polyester
  • Polyproplene
  • 6.4. Global Interatrial Shunt Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Congenital Heart Disease
  • Heart Failure
  • Stroke Prevention
  • 6.5. Global Interatrial Shunt Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Catheterization Laboratories
  • Other Users
  • 6.6. Global Interatrial Shunt Devices Market, Sub-Segmentation Of Implantable Shunt Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Lumen Shunt Devices
  • Expandable Shunt Devices
  • Multi-Lumen Shunt Devices
  • 6.7. Global Interatrial Shunt Devices Market, Sub-Segmentation Of Temporary Shunt Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Balloon-Assisted Shunt Devices
  • Percutaneous Temporary Shunt Devices
  • Catheter-Based Shunt Devices

7. Interatrial Shunt Devices Market Regional And Country Analysis

  • 7.1. Global Interatrial Shunt Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Interatrial Shunt Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Interatrial Shunt Devices Market

  • 8.1. Asia-Pacific Interatrial Shunt Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Interatrial Shunt Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Interatrial Shunt Devices Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Interatrial Shunt Devices Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Interatrial Shunt Devices Market

  • 9.1. China Interatrial Shunt Devices Market Overview
  • 9.2. China Interatrial Shunt Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Interatrial Shunt Devices Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Interatrial Shunt Devices Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Interatrial Shunt Devices Market

  • 10.1. India Interatrial Shunt Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Interatrial Shunt Devices Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Interatrial Shunt Devices Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Interatrial Shunt Devices Market

  • 11.1. Japan Interatrial Shunt Devices Market Overview
  • 11.2. Japan Interatrial Shunt Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Interatrial Shunt Devices Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Interatrial Shunt Devices Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Interatrial Shunt Devices Market

  • 12.1. Australia Interatrial Shunt Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Interatrial Shunt Devices Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Interatrial Shunt Devices Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Interatrial Shunt Devices Market

  • 13.1. Indonesia Interatrial Shunt Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Interatrial Shunt Devices Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Interatrial Shunt Devices Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Interatrial Shunt Devices Market

  • 14.1. South Korea Interatrial Shunt Devices Market Overview
  • 14.2. South Korea Interatrial Shunt Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Interatrial Shunt Devices Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Interatrial Shunt Devices Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Interatrial Shunt Devices Market

  • 15.1. Western Europe Interatrial Shunt Devices Market Overview
  • 15.2. Western Europe Interatrial Shunt Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Interatrial Shunt Devices Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Interatrial Shunt Devices Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Interatrial Shunt Devices Market

  • 16.1. UK Interatrial Shunt Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Interatrial Shunt Devices Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Interatrial Shunt Devices Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Interatrial Shunt Devices Market

  • 17.1. Germany Interatrial Shunt Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Interatrial Shunt Devices Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Interatrial Shunt Devices Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Interatrial Shunt Devices Market

  • 18.1. France Interatrial Shunt Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Interatrial Shunt Devices Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Interatrial Shunt Devices Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Interatrial Shunt Devices Market

  • 19.1. Italy Interatrial Shunt Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Interatrial Shunt Devices Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Interatrial Shunt Devices Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Interatrial Shunt Devices Market

  • 20.1. Spain Interatrial Shunt Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Interatrial Shunt Devices Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Interatrial Shunt Devices Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Interatrial Shunt Devices Market

  • 21.1. Eastern Europe Interatrial Shunt Devices Market Overview
  • 21.2. Eastern Europe Interatrial Shunt Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Interatrial Shunt Devices Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Interatrial Shunt Devices Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Interatrial Shunt Devices Market

  • 22.1. Russia Interatrial Shunt Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Interatrial Shunt Devices Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Interatrial Shunt Devices Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Interatrial Shunt Devices Market

  • 23.1. North America Interatrial Shunt Devices Market Overview
  • 23.2. North America Interatrial Shunt Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Interatrial Shunt Devices Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Interatrial Shunt Devices Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Interatrial Shunt Devices Market

  • 24.1. USA Interatrial Shunt Devices Market Overview
  • 24.2. USA Interatrial Shunt Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Interatrial Shunt Devices Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Interatrial Shunt Devices Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Interatrial Shunt Devices Market

  • 25.1. Canada Interatrial Shunt Devices Market Overview
  • 25.2. Canada Interatrial Shunt Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Interatrial Shunt Devices Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Interatrial Shunt Devices Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Interatrial Shunt Devices Market

  • 26.1. South America Interatrial Shunt Devices Market Overview
  • 26.2. South America Interatrial Shunt Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Interatrial Shunt Devices Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Interatrial Shunt Devices Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Interatrial Shunt Devices Market

  • 27.1. Brazil Interatrial Shunt Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Interatrial Shunt Devices Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Interatrial Shunt Devices Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Interatrial Shunt Devices Market

  • 28.1. Middle East Interatrial Shunt Devices Market Overview
  • 28.2. Middle East Interatrial Shunt Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Interatrial Shunt Devices Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Interatrial Shunt Devices Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Interatrial Shunt Devices Market

  • 29.1. Africa Interatrial Shunt Devices Market Overview
  • 29.2. Africa Interatrial Shunt Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Interatrial Shunt Devices Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Interatrial Shunt Devices Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Interatrial Shunt Devices Market Competitive Landscape And Company Profiles

  • 30.1. Interatrial Shunt Devices Market Competitive Landscape
  • 30.2. Interatrial Shunt Devices Market Company Profiles
    • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Medtronic plc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Interatrial Shunt Devices Market Other Major And Innovative Companies

  • 31.1. Cook Medical
  • 31.2. Integra LifeSciences Holdings Corporation
  • 31.3. Lepu Medical Technology (Beijing) Co. Ltd.
  • 31.4. B. Braun Melsungen AG.
  • 31.5. W. L. Gore & Associates Inc.
  • 31.6. Venus Medtech Inc.
  • 31.7. Occlutech Holding AG.
  • 31.8. Wuhan Vickor Medical Technology Co. Ltd.
  • 31.9. Corvia Medical Inc.
  • 31.10. Xeltis BV
  • 31.11. Alleviant Medical Inc.
  • 31.12. Cerevasc Inc.
  • 31.13. Adona Medical Inc.
  • 31.14. Carag AG.
  • 31.15. InterShunt Technologies Inc.

32. Global Interatrial Shunt Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Interatrial Shunt Devices Market

34. Recent Developments In The Interatrial Shunt Devices Market

35. Interatrial Shunt Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Interatrial Shunt Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Interatrial Shunt Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Interatrial Shunt Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer